1,377
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?

, , , , , , , , , , , , , & show all
Article: 2294332 | Received 06 Jun 2023, Accepted 24 Nov 2023, Published online: 07 Jan 2024

References

  • Abu-Zaid, A., et al., 2021a. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 258, 382–390.
  • Abu-Zaid, A., et al., 2021b. Preoperative leukocytosis correlates with unfavorable pathological and survival outcomes in endometrial carcinoma: A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 264, 88–96.
  • Bai, Y. Y., et al., 2019. Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis. Cancer Management and Research, 11, 4283–4295.
  • Berridge, M. V., et al., 1988. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. Blood, 72 (3), 970–977.
  • Birgegård, G., et al., 2005. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology, 68 Suppl 1, 3–11.
  • Bokhman, J. V., 1983. Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology, 15 (1), 10–17.
  • Bouwman, F., et al., 2015. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery–an institutional study and systematic review of the literature. Gynecologic Oncology, 139 (2), 369–376.
  • Cho, Y., et al., 2016. Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 27 (11), 2067–2074.
  • Concin, N., et al., 2021. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 31 (1), 12–39.
  • Durand, R. E., 1991. Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. International Journal of Radiation Oncology, Biology, Physics, 20 (2), 253–258.
  • Giampaolino, P., et al., 2022. Fertility-sparing approach in patients with endometrioid endometrial cancer Grade 2 Stage IA (FIGO): a qualitative systematic review. BioMed Research International, 2022, 4070368.
  • Gullo, G., et al., 2023. Fertility-sparing strategies for early-stage endometrial cancer: stepping towards precision medicine based on the molecular fingerprint. International Journal of Molecular Sciences, 24 (1), 811.
  • Gullo, G., Perino, A. and Cucinella, G., 2022. Open vs. closed vitrification system: which one is safer? European Review for Medical and Pharmacological Sciences, 26 (4), 1065–1067.
  • Gynaecologie, W. O., 2018. Landelijke richtlijn endometriumcarcinoom [Online]. Available from: https://richtlijnendatabase.nl/gerelateerde_documenten/f/13044/IKNL%20richtlijn%20Endometriumcarcinoom.pdf.
  • Koukourakis, M. I., et al., 2000. Cancer vascularization: implications in radiotherapy? International Journal of Radiation Oncology, Biology, Physics, 48 (2), 545–553.
  • Li, N., 2016. Platelets in cancer metastasis: To help the "villain" to do evil. International Journal of Cancer, 138 (9), 2078–2087.
  • Mantovani, A., et al., 2008. Cancer-related inflammation. Nature, 454 (7203), 436–444.
  • Mclean, E., et al., 2009. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutrition, 12 (4), 444–454.
  • Modugno, F., et al., 2005. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiology, Biomarkers & Prevention, 14 (12), 2840–2847.
  • Moliterno, A. R. and Spivak, J. L., 1996. Anemia of cancer. Hematology/Oncology Clinics of North America, 10 (2), 345–363.
  • Moon, E. J., Petersson, K. and Olcina, M. M., 2022. The importance of hypoxia in radiotherapy for the immune response, metastatic potential and FLASH-RT. International Journal of Radiation Biology, 98 (3), 439–451.
  • Mutlu, L., et al., 2022. Endometrial cancer in reproductive age: fertility-sparing approach and reproductive outcomes. Cancers, 14 (21), 5187.
  • Nie, D., Yang, E. and Li, Z., 2019. Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis. BMC Cancer, 19 (1), 73.
  • Njølstad, T. S., et al., 2013. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecologic Oncology, 131 (2), 410–415.
  • Nordsmark, M. and Overgaard, J., 2004. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncologica (Stockholm, Sweden), 43 (4), 396–403.
  • Obermair, A., et al., 1998. The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer, 83 (4), 726–731.
  • Reijnen, C., et al., 2020. Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. PLoS Medicine, 17 (5), e1003111.
  • Salem, H., et al., 2020. Preoperative leukocytosis as a prognostic marker in endometrioid-type endometrial cancer: a single-center experience from Saudi Arabia. The Gulf Journal of Oncology, 1 (32), 51–58.
  • Sundar, B. J., et al., 2017. BGCS Uterine Cancer Guidelines: Recommendations for Practice [Online]. Available from: https://www.bgcs.org.uk/wp-content/uploads/2019/05/BGCS-Endometrial-Guidelines-2017.pdf
  • Tamussino, K. F., et al., 2001. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 11 (3), 236–240.
  • Tanos, P., et al., 2022. Biomolecular and genetic prognostic factors that can facilitate fertility-sparing treatment (FST) decision making in early stage endometrial cancer (ES-EC): a systematic review. International Journal of Molecular Sciences, 23 (5), 2653.
  • Visser, N. C., et al., 2015. PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study. BMC Cancer, 15 (1), 487.
  • Wilairat, W. and Benjapibal, M., 2012. Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pacific Journal of Cancer Prevention: Apjcp, 13 (7), 3187–3190.
  • Worley, M. J., Jr., et al., 2012. The significance of preoperative leukocytosis in endometrial carcinoma. Gynecologic Oncology, 125 (3), 561–565.
  • Ye, Q., et al., 2020. Pre-treatment thrombocytosis predicts prognosis of endometrial cancer: A meta-analysis of 11 studies. Experimental and Therapeutic Medicine, 19 (1), 359–366.
  • Zaami, S., et al., 2022. Fertility preservation in female cancer sufferers: (only) a moral obligation? The European Journal of Contraception & Reproductive Health Care: The Official Journal of the European Society of Contraception, 27 (4), 335–340.